Ralph Schwall
Publications by Year
Research Areas
Liver physiology and pathology, TGF-β signaling in diseases, Growth Hormone and Insulin-like Growth Factors, Pancreatic and Hepatic Oncology Research, Cancer Cells and Metastasis
Most-Cited Works
- → Safety and antitumor activity of recombinant soluble Apo2 ligand(1999)2,210 cited
- → Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate(2008)1,659 cited
- → Vascular endothelial growth factor is essential for corpus luteum angiogenesis(1998)629 cited
- → Tumor-cell resistance to death receptor–induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax(2002)506 cited
- → Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer(2006)481 cited
- → Potentiated Angiogenic Effect of Scatter Factor/Hepatocyte Growth Factor via Induction of Vascular Endothelial Growth Factor(1998)442 cited
- → Hepatocyte Growth Factor Enhances Vascular Endothelial Growth Factor-Induced Angiogenesis in Vitro and in Vivo(2001)394 cited
- → A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth In vivo(2006)302 cited
- → Evidence for an Autocrine Role of Activin B within Rat Anterior Pituitary Cultures(1991)267 cited
- → Imaging Tumors with an Albumin-Binding Fab, a Novel Tumor-Targeting Agent(2007)247 cited